Risk of Severe COVID-19 in Non-Adherent OSA Patients

J 2022

Risk of Severe COVID-19 in Non-Adherent OSA Patients

GENZOR, Samuel; Jan PRASKO; Jan MIZERA; Petr JAKUBEC; Milan SOVA et. al.

Základní údaje

Originální název

Risk of Severe COVID-19 in Non-Adherent OSA Patients

Autoři

GENZOR, Samuel (203 Česká republika); Jan PRASKO (203 Česká republika, garant); Jan MIZERA (203 Česká republika); Petr JAKUBEC (203 Česká republika); Milan SOVA (203 Česká republika, domácí); Jakub VANEK (203 Česká republika); Nikoleta SURINOVA (203 Česká republika) a Katerina LANGOVA (203 Česká republika)

Vydání

PATIENT PREFERENCE AND ADHERENCE, AUCKLAND, DOVE MEDICAL PRESS LTD, 2022, 1177-889X

Další údaje

Jazyk

angličtina

Typ výsledku

Článek v odborném periodiku

Obor

30203 Respiratory systems

Stát vydavatele

Spojené státy

Utajení

není předmětem státního či obchodního tajemství

Odkazy

URL

Impakt faktor

Impact factor: 2.200

Kód RIV

RIV/00216224:14110/22:00128092

Organizační jednotka

Lékařská fakulta

DOI

http://dx.doi.org/10.2147/PPA.S387657

UT WoS

000884754000001

EID Scopus

2-s2.0-85141348758

Klíčová slova anglicky

OSA; COVID-19; vaccination; treatment with CPAP; CPAP adherence

Štítky

14110215, rivok

Příznaky

Mezinárodní význam, Recenzováno

Změněno: 18. 1. 2023 12:58, Mgr. Tereza Miškechová

Anotace

V originále

Background: Patients with obstructive sleep apnoea (OSA) are at increased risk of severe course of COVID-19. Vaccination remains to be the most effective prevention of complicated courses of infection. The best contemporary conservative treatment of OSA is continuous positive airway pressure (CPAP) therapy.Purpose: To compare vaccination acceptance and outcomes of COVID-19 infection between OSA patients adhering to the CPAP therapy and those who rejected CPAP and surgical therapy.Patients and Methods: Subjects were divided into two groups: group A (N = 167) were individuals with sufficient CPAP adherence (more than 4 hours per night on average) over the last 10 years. Group B (N = 106) were individuals who did not use the CPAP therapy at all and had no indications to surgical therapy.Results: Three patients in group B died, and one had a severe course of COVID-19. None of the patients in group A died or experienced a severe course of COVID-19. Group A had a significantly higher proportion of males (77.8% compared to 66% in group B) and all parameters of OSA severity. The vaccination status was similar among both groups, with a complete triple dose vaccination rate of 69.5% and 67.9% in groups A and B, respectively. Conclusion: The results show that the patients with OSA adherent to CPAP therapy were less likely to experience a severe course of COVID-19 or death than the OSA patients non-compliant with therapy, despite the former group having more severe OSA. This result underlines the importance of adherence to CPAP therapy in OSA.

Citovat

GENZOR, Samuel; Jan PRASKO; Jan MIZERA; Petr JAKUBEC; Milan SOVA; Jakub VANEK; Nikoleta SURINOVA a Katerina LANGOVA. Risk of Severe COVID-19 in Non-Adherent OSA Patients. PATIENT PREFERENCE AND ADHERENCE. AUCKLAND: DOVE MEDICAL PRESS LTD, 2022, roč. 16, November 2022, s. 3069-3079. ISSN 1177-889X. Dostupné z: https://dx.doi.org/10.2147/PPA.S387657.

@article{2247601,
   author = {Genzor, Samuel and Prasko, Jan and Mizera, Jan and Jakubec, Petr and Sova, Milan and Vanek, Jakub and Surinova, Nikoleta and Langova, Katerina},
   article_location = {AUCKLAND},
   article_number = {November 2022},
   doi = {http://dx.doi.org/10.2147/PPA.S387657},
   keywords = {OSA; COVID-19; vaccination; treatment with CPAP; CPAP adherence},
   language = {eng},
   issn = {1177-889X},
   journal = {PATIENT PREFERENCE AND ADHERENCE},
   title = {Risk of Severe COVID-19 in Non-Adherent OSA Patients},
   url = {https://www.dovepress.com/risk-of-severe-covid-19-in-non-adherent-osa-patients-peer-reviewed-fulltext-article-PPA},
   volume = {16},
   year = {2022}
}

TY  - JOUR
ID  - 2247601
AU  - Genzor, Samuel - Prasko, Jan - Mizera, Jan - Jakubec, Petr - Sova, Milan - Vanek, Jakub - Surinova, Nikoleta - Langova, Katerina
PY  - 2022
TI  - Risk of Severe COVID-19 in Non-Adherent OSA Patients
JF  - PATIENT PREFERENCE AND ADHERENCE
VL  - 16
IS  - November 2022
SP  - 3069-3079
EP  - 3069-3079
PB  - DOVE MEDICAL PRESS LTD
SN  - 1177889X
KW  - OSA
KW  - COVID-19
KW  - vaccination
KW  - treatment with CPAP
KW  - CPAP adherence
UR  - https://www.dovepress.com/risk-of-severe-covid-19-in-non-adherent-osa-patients-peer-reviewed-fulltext-article-PPA
N2  - Background: Patients with obstructive sleep apnoea (OSA) are at increased risk of severe course of COVID-19. Vaccination remains to be the most effective prevention of complicated courses of infection. The best contemporary conservative treatment of OSA is continuous positive airway pressure (CPAP) therapy.Purpose: To compare vaccination acceptance and outcomes of COVID-19 infection between OSA patients adhering to the CPAP therapy and those who rejected CPAP and surgical therapy.Patients and Methods: Subjects were divided into two groups: group A (N = 167) were individuals with sufficient CPAP adherence (more than 4 hours per night on average) over the last 10 years. Group B (N = 106) were individuals who did not use the CPAP therapy at all and had no indications to surgical therapy.Results: Three patients in group B died, and one had a severe course of COVID-19. None of the patients in group A died or experienced a severe course of COVID-19. Group A had a significantly higher proportion of males (77.8% compared to 66% in group B) and all parameters of OSA severity. The vaccination status was similar among both groups, with a complete triple dose vaccination rate of 69.5% and 67.9% in groups A and B, respectively. Conclusion: The results show that the patients with OSA adherent to CPAP therapy were less likely to experience a severe course of COVID-19 or death than the OSA patients non-compliant with therapy, despite the former group having more severe OSA. This result underlines the importance of adherence to CPAP therapy in OSA.
ER  -

GENZOR, Samuel; Jan PRASKO; Jan MIZERA; Petr JAKUBEC; Milan SOVA; Jakub VANEK; Nikoleta SURINOVA a Katerina LANGOVA. Risk of Severe COVID-19 in Non-Adherent OSA Patients. \textit{PATIENT PREFERENCE AND ADHERENCE}. AUCKLAND: DOVE MEDICAL PRESS LTD, 2022, roč.~16, November 2022, s.~3069-3079. ISSN~1177-889X. Dostupné z: https://dx.doi.org/10.2147/PPA.S387657.

Přehled o publikaci